May 20 2020

Babson Diagnostics Enters Collaborative Research Agreement with Dell Medical School to Study Immune Response to COVID-19

Austin, Texas - Babson Diagnostics, a transformative diagnostic blood testing company, announced today it has entered into a collaborative research agreement with Dell Medical School at The University of Texas at Austin (Dell Med) to study the immune response to COVID-19.… Read More >

Apr 30 2020

Babson Diagnostics Launches COVID-19 Serology Test for IgG Antibodies with 100% Specificity in Austin

Austin, Texas - Babson Diagnostics, a transformative diagnostic blood testing company, announced today it has launched its first COVID-19 serology test to detect IgG antibodies to SARS-CoV-2 in the bloodstream through a select network of retail and clinical partners in… Read More >

Apr 15 2020

Babson Diagnostics to Offer High-Throughput COVID-19 Serology Testing in Austin, Texas

Austin, Texas -  Babson Diagnostics, a transformative diagnostic blood testing company, announced today it will launch a COVID-19 serology testing service. COVID-19 serology testing is used to detect the presence of antibodies to SARS-CoV-2 in the bloodstream, which makes… Read More >

Mar 11 2020

Babson Diagnostics Bolsters Board of Directors with Three Diagnostics Industry Experts

Austin, Texas -  Babson Diagnostics, a transformative diagnostic blood testing company, announced today that it has expanded its board of directors to include diagnostics industry leaders David Stein (Director), Dennis Gilbert (Director), and Dave Hickey… Read More >

Feb 12 2020

BD, Babson Diagnostics Announce Strategic Partnership Agreement to Enable Small-Volume Blood Collection for Diagnostic Testing in Retail Settings

Franklin Lakes, N.J. and Austin, Texas - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and Babson Diagnostics, a transformative diagnostic blood testing company, today announced a long-term strategic partnership agreement to… Read More >

Jul 30 2019

Babson Diagnostics announces its Scientific Advisory Board

Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, has established its Scientific Advisory Board. Drs. Alan Wu, Susan A. Evans, and Robert H. Christenson will join the Babson team as… Read More >

May 23 2019

Babson Diagnostics Wins Austin A-List Award

Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, was named a winner at the Greater Austin Chamber of Commerce’s 2019 Austin A-List Awards, “Austin’s premiere honor for homegrown… Read More >

May 14 2019

Babson Diagnostics welcomes Mini Kahlon to its Board of Directors

Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, welcomed Mini Kahlon as the newest member of its Board of Directors. Regarding her commitment to Babson’s success, Mini expressed, “I… Read More >

Mar 11 2019

Babson Diagnostics featured in Capital City Innovation Annual Report

Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, was featured today in Capital City Innovation's 2018 Annual Review. Capital City Innovation is a 501(c)(3) nonprofit focused on… Read More >

Oct 19 2018

Babson Diagnostics secures $3.5 million in Series A financing from Prism Ventures

Austin, Texas - Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, secured $3.5 million in Series A financing on October 4 from Prism Ventures, a New York-based advisory and investment firm specializing in… Read More >